Nayak Sanjay 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 26, 2024
Insider Transaction Report
Form 4
Nayak Sanjay
Chief Strategy Officer
Transactions
- Award
Common Stock
2024-02-22+80,300→ 180,300 total - Award
Stock Option (Right to Buy)
2024-02-22+244,550→ 244,550 totalExercise: $9.70Exp: 2024-02-21→ Common Stock (244,550 underlying)
Footnotes (2)
- [F1]On February 22, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal quarterly installments, beginning on the date of grant.
- [F2]Vests over four years, with 1/4 of the shares underlying the option vesting on the one-year anniversary of the date the reporting person commenced employment with the Corporation and 1/48 of the shares underlying the option vesting monthly thereafter.